Director of Research Services and Innovation
BSc (Hons) DPhil (Oxon)
After graduating from The University of Western Australia, Paul Watt completed his doctorate in Molecular Biology at Oxford University before taking up postdoctoral appointments at Harvard and Oxford and then at the Telethon Kids Institute, working primarily in genome stability, yeast genetics and transcriptional regulation. He was appointed Adjunct Professor at The University for Western Australia and is Director of Research Services and Innovation at the Telethon Kids, where he responsible for technology transfer and licensing activities. Professor Watt is also head of the Telethon Kids’ Drug Discovery Unit which offers contract research services to the pharmaceutical industry.
Professor Watt has published 58 peer reviewed scientific papers and is primary inventor on 25 patent applications, most of which have been granted in the US and Europe and other jurisdictions. Professor Watt is focused on technology translation, having founded InfaMed Ltd., now owned by Avita Medical, which commercialised a globally marketed drug delivery device which he invented.
Professor Watt is the founder and scientific adviser of Phylogica, a publicly-listed drug discovery spin-off from Telethon Kids, which he founded to commercialise a novel, structure-rich class of peptide known as Phylomers. Phylogica has entered into discovery alliances with several large Pharmaceutical companies including Janssen, Medimmune, Pfizer and Roche/Genentech and is commercialising a more efficient approach for intracellular delivery of biologics.